Scholarlink

Introduction <p>Extracorporeal membrane oxygenation (ECMO) is a&#xa0;therapeutic option for otherwise refractory pulmonary or cardiac failure. While ECMO therapy, as a&#xa0;highly invasive and high-risk procedure, is primarily offered at specialized centers, the time between the indication for and the implementation of ECMO therapy is outcome-relevant. This raises the question of whether ECMO therapy can be safely and successfully implemented in peripheral hospitals.</p> Methods <p>This retrospective analysis comprised all ECMO patients of a&#xa0;regional hospital for the period 2013–2023. Demographic data as well as therapy and survival data were recorded.</p> Results <p>During the 10-year observation period, 54&#xa0;ECMO treatments were performed at the center (53&#xa0;venovenous ECMO, 1&#xa0;venoarterial ECMO), of which four were transferred to a&#xa0;specialized center after the therapy was initiated. Of the remaining 50&#xa0;patients, 24&#xa0;survived the intensive care therapy (48%).</p> Conclusion <p>The present study demonstrates that ECMO therapies can be performed safely and with similar outcomes at peripheral hospitals, particularly if supported by a&#xa0;collaborating specialized center. Thus, transfers to specialized centers can be limited to patients with complicated courses.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ECMO-Therapien an einem peripheren Krankenhaus

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月23日

查看全文
  • Dominik J. Hoechter,
  • Bernhard Oss,
  • Martin Schmölz,
  • Patrick Scheiermann

摘要

Introduction

Extracorporeal membrane oxygenation (ECMO) is a therapeutic option for otherwise refractory pulmonary or cardiac failure. While ECMO therapy, as a highly invasive and high-risk procedure, is primarily offered at specialized centers, the time between the indication for and the implementation of ECMO therapy is outcome-relevant. This raises the question of whether ECMO therapy can be safely and successfully implemented in peripheral hospitals.

Methods

This retrospective analysis comprised all ECMO patients of a regional hospital for the period 2013–2023. Demographic data as well as therapy and survival data were recorded.

Results

During the 10-year observation period, 54 ECMO treatments were performed at the center (53 venovenous ECMO, 1 venoarterial ECMO), of which four were transferred to a specialized center after the therapy was initiated. Of the remaining 50 patients, 24 survived the intensive care therapy (48%).

Conclusion

The present study demonstrates that ECMO therapies can be performed safely and with similar outcomes at peripheral hospitals, particularly if supported by a collaborating specialized center. Thus, transfers to specialized centers can be limited to patients with complicated courses.